CN Stock MarketDetailed Quotes

002773 Chengdu Kanghong Pharmaceutical Group

Watchlist
  • 22.71
  • -0.76-3.24%
Market Closed Jun 7 15:00 CST
20.88BMarket Cap18.33P/E (TTM)

Chengdu Kanghong Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Money funds
45.62%3.11B
31.15%4.7B
60.99%2.53B
72.81%2.98B
11.66%2.14B
22.00%3.59B
-23.15%1.57B
-31.35%1.73B
38.41%1.91B
-11.68%2.94B
Transactional financial assets
15.67%1.95B
----
22.21%1.97B
-14.54%1.07B
23.04%1.69B
-50.00%100M
40.16%1.61B
144.32%1.25B
-29.54%1.37B
--200M
Notes receivable and accounts receivable
-24.34%170.17M
-0.17%160.41M
-10.44%186.22M
-23.19%185.37M
0.59%224.92M
-21.48%160.69M
-33.59%207.94M
-19.11%241.34M
-30.05%223.6M
-40.89%204.63M
-Notes receivable
----
----
-87.03%2.72M
-88.03%3.02M
-77.45%5.61M
-48.39%11.07M
21.38%20.99M
96.87%25.21M
7.78%24.9M
35.70%21.44M
-Accounts receivable
-22.40%170.17M
7.21%160.41M
-1.85%183.5M
-15.63%182.36M
10.37%219.31M
-18.32%149.62M
-36.80%186.95M
-24.31%216.13M
-33.00%198.7M
-44.56%183.19M
Other receivables (including interest and dividends)
-1.40%18.59M
-35.87%7.05M
-43.78%10.23M
-27.72%7.09M
13.73%18.85M
685.15%10.99M
80.60%18.2M
513.18%9.8M
15.39%16.58M
-39.57%1.4M
-Other receivable
----
----
----
-27.72%7.09M
----
685.15%10.99M
----
513.18%9.8M
----
-39.57%1.4M
Advance payment
-45.20%18.68M
-56.37%10.48M
-15.68%32.45M
-10.36%27.39M
42.37%34.09M
52.28%24.02M
68.60%38.48M
105.60%30.56M
-9.80%23.95M
-30.24%15.78M
Inventories
17.16%401.55M
21.95%403.61M
22.05%377.07M
24.75%366.07M
21.31%342.73M
11.95%330.96M
15.07%308.95M
23.29%293.45M
19.69%282.54M
23.36%295.62M
Other current assets
15.71%23.41M
28.24%21.92M
26.56%15.93M
-5.72%23.79M
-55.31%20.24M
-59.60%17.09M
-64.34%12.58M
-52.54%25.23M
49.40%45.28M
80.75%42.31M
Total current assets
27.57%5.7B
25.45%5.31B
35.86%5.12B
30.33%4.66B
15.16%4.47B
14.34%4.23B
-1.94%3.77B
-1.54%3.57B
-1.99%3.88B
-6.64%3.7B
Non Current assets
Long-term equity investment
-0.87%16.72M
-1.22%16.78M
-3.33%16.73M
-4.17%16.76M
-4.04%16.87M
-4.22%16.98M
-3.63%17.31M
-3.21%17.49M
-3.42%17.58M
-3.38%17.73M
Fixed assets
----
----
----
79.87%2.23B
----
61.62%2.06B
----
7.67%1.24B
----
8.77%1.28B
Constru in process
----
----
----
-78.38%230.48M
----
-41.15%475.88M
----
39.90%1.07B
----
33.22%808.69M
Productive biological assets
-50.61%4.07M
-47.13%4.55M
-39.42%4.86M
-33.73%5.59M
55.85%8.25M
75.99%8.61M
137.97%8.02M
341.79%8.44M
2,130.54%5.29M
7,956.80%4.89M
Intangible assets
-4.02%309.15M
-4.33%316.8M
-3.00%320.61M
-3.42%322.53M
18.76%322.09M
19.02%331.14M
18.24%330.53M
18.25%333.96M
-6.11%271.2M
-5.42%278.21M
Development expenditure
39.89%93.52M
48.67%92.14M
92.97%82.79M
160.68%74.5M
-21.86%66.85M
-15.81%61.98M
-31.39%42.9M
-52.52%28.58M
53.41%85.55M
38.25%73.62M
Long deferred expense
-20.22%6.18M
-15.25%7.19M
-26.96%6.38M
-24.62%7.38M
-22.78%7.75M
-23.20%8.48M
639.56%8.74M
469.39%9.79M
532.99%10.04M
378.03%11.05M
Deferred tax assets
-33.07%312.28M
-26.37%358.08M
-21.61%386.19M
-15.53%430.48M
-11.86%466.55M
-10.88%486.31M
1.79%492.63M
7.02%509.62M
17.23%529.3M
26.89%545.66M
Usufruct assets
-52.34%1.99M
-54.94%2.12M
-35.87%3.38M
-32.56%3.86M
-33.62%4.17M
-31.36%4.71M
0.76%5.26M
34.88%5.72M
41.01%6.29M
244.58%6.87M
Other non current assets
-28.90%23.75M
-35.11%22.01M
-95.45%27.57M
-93.03%36.09M
-87.84%33.41M
-85.49%33.93M
130.15%605.76M
112.16%517.68M
-5.47%274.83M
-4.65%233.89M
Total non current assets
-8.60%3.14B
-7.66%3.22B
-14.84%3.27B
-10.13%3.36B
0.59%3.43B
7.19%3.49B
15.66%3.84B
16.16%3.74B
8.96%3.41B
7.11%3.26B
Total assets
11.85%8.83B
10.48%8.53B
10.25%8.39B
9.64%8.02B
8.34%7.9B
10.99%7.72B
6.22%7.61B
6.78%7.31B
2.85%7.29B
-0.67%6.96B
Liabilities
Current liabilities
Notes payable and accounts payable
-24.23%255.97M
-16.00%344.03M
-0.54%301.45M
20.38%340.28M
-6.00%337.83M
19.35%409.54M
26.76%303.09M
17.33%282.68M
62.45%359.41M
18.78%343.13M
-Accounts payable
-24.23%255.97M
-16.00%344.03M
-0.54%301.45M
20.38%340.28M
-6.00%337.83M
19.35%409.54M
26.76%303.09M
17.33%282.68M
62.45%359.41M
18.78%343.13M
Contract liabilities
79.56%6.67M
-44.21%5.1M
37.21%6.84M
-3.03%6.23M
-57.81%3.71M
8.94%9.14M
-19.70%4.98M
-39.28%6.43M
-44.84%8.8M
-29.11%8.39M
Advance receipts
161.18%16.27M
92.91%3.88M
25.16%4M
-65.38%2.65M
-81.93%6.23M
-58.27%2.01M
21.36%3.2M
126.33%7.67M
86.62%34.47M
-26.72%4.82M
Salaries payable
-1.13%38.68M
30.73%133.98M
5.23%22.93M
80.73%40.13M
74.18%39.13M
4.37%102.49M
-3.90%21.79M
-2.98%22.2M
-2.60%22.46M
-1.21%98.2M
Taxs payable
-29.47%55.22M
-12.45%35.95M
2.33%55.47M
-26.46%47.03M
16.23%78.29M
10.12%41.06M
-11.27%54.21M
0.78%63.95M
-24.84%67.36M
-49.84%37.29M
Other payable (including interest and dividends)
65.48%181.44M
-2.24%64.36M
16.82%268.34M
1.52%147.44M
-9.97%109.64M
-7.67%65.83M
-3.59%229.7M
6.28%145.24M
-71.43%121.79M
-82.30%71.3M
-Other payable
----
----
----
1.52%147.44M
----
-7.67%65.83M
----
6.28%145.24M
----
-82.30%71.3M
Non current liabilities due within one year
-11.33%407.56K
-66.72%531.82K
-26.42%1.31M
-12.28%1.68M
-39.70%459.63K
-37.77%1.6M
--1.77M
--1.92M
--762.18K
178.15%2.57M
Other current liabilities
26.89%39.83M
7.44%66.59M
-22.01%56.63M
-23.38%49.26M
-63.38%31.39M
-39.04%61.98M
11.21%72.6M
16.56%64.29M
61.48%85.73M
6.01%101.67M
Total current liabilities
-2.01%594.5M
-5.66%654.43M
3.71%716.96M
6.78%634.71M
-13.43%606.68M
3.94%693.66M
8.83%691.35M
11.50%594.39M
-17.34%700.79M
-31.94%667.37M
Current liabilities
Long term account payable
----
----
----
--0
----
--0
----
--0
----
--0
Specific account payable
----
----
----
-48.23%61.37M
----
-41.66%88.51M
----
-35.65%118.54M
----
-30.25%151.71M
Deferred tax liabilities
51.62%8.58M
54.56%7.94M
276.06%6.88M
229.59%6.28M
185.23%5.66M
149.43%5.14M
-14.42%1.83M
-13.92%1.91M
-13.45%1.98M
-13.01%2.06M
Long term deferred income
-18.90%18.54M
-25.63%17.31M
3.94%22.02M
-0.46%22.44M
-4.87%22.86M
-8.77%23.27M
-42.91%21.19M
-43.37%22.54M
-43.90%24.03M
-43.56%25.51M
Lease liabilities
-63.40%1.52M
-54.73%1.48M
-49.08%1.65M
-43.10%1.8M
-8.29%4.15M
-26.27%3.27M
-33.98%3.25M
-15.73%3.17M
23.29%4.52M
319.75%4.43M
Total non current liabilities
-47.97%55.48M
-47.31%63.33M
-38.90%79.79M
-37.12%91.9M
-35.24%106.64M
-34.58%120.19M
-38.16%130.58M
-36.56%146.16M
-34.20%164.66M
-31.07%183.71M
Total liabilities
-8.88%649.98M
-11.81%717.76M
-3.06%796.75M
-1.88%726.61M
-17.58%713.32M
-4.37%813.85M
-2.89%821.93M
-3.00%740.55M
-21.18%865.44M
-31.76%851.08M
Shareholders equity
Paid-in capital
0.00%919.46M
0.00%919.46M
0.00%919.46M
0.00%919.46M
0.00%919.46M
0.00%919.46M
0.00%919.46M
0.00%919.46M
0.00%919.46M
0.00%919.46M
Capital reserve funds
-0.22%1.99B
-0.22%1.99B
-0.23%1.99B
0.26%2B
0.30%1.99B
0.38%1.99B
0.43%1.99B
0.46%1.99B
0.37%1.99B
0.26%1.99B
Surplus reserve funds
5.95%515.32M
7.16%515.32M
3.13%489.68M
3.15%487.16M
3.73%486.36M
4.54%480.87M
3.07%474.81M
3.81%472.27M
27.82%468.89M
29.31%460M
Retained profit
25.70%4.75B
24.86%4.38B
24.15%4.19B
23.19%3.89B
25.53%3.78B
28.77%3.51B
14.09%3.37B
15.70%3.16B
10.68%3.01B
9.00%2.72B
Other composite income
-41.95%-1.93M
-27.74%-1.34M
-96.30%-1.26M
6.54%-1.1M
-29.45%-1.36M
-26.53%-1.05M
21.52%-639.45K
-73.78%-1.17M
-69.88%-1.05M
-106.25%-829.94K
Shareholders equity without minority interests
13.87%8.18B
13.07%7.8B
12.20%7.58B
11.50%7.29B
12.40%7.18B
13.33%6.9B
6.95%6.76B
7.47%6.54B
6.67%6.39B
5.80%6.09B
Minority interests
98.93%5.84M
55.52%7.89M
-60.15%12.39M
-101.72%-560.35K
-91.63%2.94M
-66.71%5.07M
--31.09M
--32.64M
--35.09M
--15.24M
Total shareholder equity
13.91%8.18B
13.10%7.81B
11.86%7.6B
10.94%7.29B
11.83%7.18B
13.13%6.91B
7.45%6.79B
8.01%6.57B
7.26%6.42B
6.07%6.1B
Total liabilityies and equity
11.85%8.83B
10.48%8.53B
10.25%8.39B
9.64%8.02B
8.34%7.9B
10.99%7.72B
6.22%7.61B
6.78%7.31B
2.85%7.29B
-0.67%6.96B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Money funds 45.62%3.11B31.15%4.7B60.99%2.53B72.81%2.98B11.66%2.14B22.00%3.59B-23.15%1.57B-31.35%1.73B38.41%1.91B-11.68%2.94B
Transactional financial assets 15.67%1.95B----22.21%1.97B-14.54%1.07B23.04%1.69B-50.00%100M40.16%1.61B144.32%1.25B-29.54%1.37B--200M
Notes receivable and accounts receivable -24.34%170.17M-0.17%160.41M-10.44%186.22M-23.19%185.37M0.59%224.92M-21.48%160.69M-33.59%207.94M-19.11%241.34M-30.05%223.6M-40.89%204.63M
-Notes receivable ---------87.03%2.72M-88.03%3.02M-77.45%5.61M-48.39%11.07M21.38%20.99M96.87%25.21M7.78%24.9M35.70%21.44M
-Accounts receivable -22.40%170.17M7.21%160.41M-1.85%183.5M-15.63%182.36M10.37%219.31M-18.32%149.62M-36.80%186.95M-24.31%216.13M-33.00%198.7M-44.56%183.19M
Other receivables (including interest and dividends) -1.40%18.59M-35.87%7.05M-43.78%10.23M-27.72%7.09M13.73%18.85M685.15%10.99M80.60%18.2M513.18%9.8M15.39%16.58M-39.57%1.4M
-Other receivable -------------27.72%7.09M----685.15%10.99M----513.18%9.8M-----39.57%1.4M
Advance payment -45.20%18.68M-56.37%10.48M-15.68%32.45M-10.36%27.39M42.37%34.09M52.28%24.02M68.60%38.48M105.60%30.56M-9.80%23.95M-30.24%15.78M
Inventories 17.16%401.55M21.95%403.61M22.05%377.07M24.75%366.07M21.31%342.73M11.95%330.96M15.07%308.95M23.29%293.45M19.69%282.54M23.36%295.62M
Other current assets 15.71%23.41M28.24%21.92M26.56%15.93M-5.72%23.79M-55.31%20.24M-59.60%17.09M-64.34%12.58M-52.54%25.23M49.40%45.28M80.75%42.31M
Total current assets 27.57%5.7B25.45%5.31B35.86%5.12B30.33%4.66B15.16%4.47B14.34%4.23B-1.94%3.77B-1.54%3.57B-1.99%3.88B-6.64%3.7B
Non Current assets
Long-term equity investment -0.87%16.72M-1.22%16.78M-3.33%16.73M-4.17%16.76M-4.04%16.87M-4.22%16.98M-3.63%17.31M-3.21%17.49M-3.42%17.58M-3.38%17.73M
Fixed assets ------------79.87%2.23B----61.62%2.06B----7.67%1.24B----8.77%1.28B
Constru in process -------------78.38%230.48M-----41.15%475.88M----39.90%1.07B----33.22%808.69M
Productive biological assets -50.61%4.07M-47.13%4.55M-39.42%4.86M-33.73%5.59M55.85%8.25M75.99%8.61M137.97%8.02M341.79%8.44M2,130.54%5.29M7,956.80%4.89M
Intangible assets -4.02%309.15M-4.33%316.8M-3.00%320.61M-3.42%322.53M18.76%322.09M19.02%331.14M18.24%330.53M18.25%333.96M-6.11%271.2M-5.42%278.21M
Development expenditure 39.89%93.52M48.67%92.14M92.97%82.79M160.68%74.5M-21.86%66.85M-15.81%61.98M-31.39%42.9M-52.52%28.58M53.41%85.55M38.25%73.62M
Long deferred expense -20.22%6.18M-15.25%7.19M-26.96%6.38M-24.62%7.38M-22.78%7.75M-23.20%8.48M639.56%8.74M469.39%9.79M532.99%10.04M378.03%11.05M
Deferred tax assets -33.07%312.28M-26.37%358.08M-21.61%386.19M-15.53%430.48M-11.86%466.55M-10.88%486.31M1.79%492.63M7.02%509.62M17.23%529.3M26.89%545.66M
Usufruct assets -52.34%1.99M-54.94%2.12M-35.87%3.38M-32.56%3.86M-33.62%4.17M-31.36%4.71M0.76%5.26M34.88%5.72M41.01%6.29M244.58%6.87M
Other non current assets -28.90%23.75M-35.11%22.01M-95.45%27.57M-93.03%36.09M-87.84%33.41M-85.49%33.93M130.15%605.76M112.16%517.68M-5.47%274.83M-4.65%233.89M
Total non current assets -8.60%3.14B-7.66%3.22B-14.84%3.27B-10.13%3.36B0.59%3.43B7.19%3.49B15.66%3.84B16.16%3.74B8.96%3.41B7.11%3.26B
Total assets 11.85%8.83B10.48%8.53B10.25%8.39B9.64%8.02B8.34%7.9B10.99%7.72B6.22%7.61B6.78%7.31B2.85%7.29B-0.67%6.96B
Liabilities
Current liabilities
Notes payable and accounts payable -24.23%255.97M-16.00%344.03M-0.54%301.45M20.38%340.28M-6.00%337.83M19.35%409.54M26.76%303.09M17.33%282.68M62.45%359.41M18.78%343.13M
-Accounts payable -24.23%255.97M-16.00%344.03M-0.54%301.45M20.38%340.28M-6.00%337.83M19.35%409.54M26.76%303.09M17.33%282.68M62.45%359.41M18.78%343.13M
Contract liabilities 79.56%6.67M-44.21%5.1M37.21%6.84M-3.03%6.23M-57.81%3.71M8.94%9.14M-19.70%4.98M-39.28%6.43M-44.84%8.8M-29.11%8.39M
Advance receipts 161.18%16.27M92.91%3.88M25.16%4M-65.38%2.65M-81.93%6.23M-58.27%2.01M21.36%3.2M126.33%7.67M86.62%34.47M-26.72%4.82M
Salaries payable -1.13%38.68M30.73%133.98M5.23%22.93M80.73%40.13M74.18%39.13M4.37%102.49M-3.90%21.79M-2.98%22.2M-2.60%22.46M-1.21%98.2M
Taxs payable -29.47%55.22M-12.45%35.95M2.33%55.47M-26.46%47.03M16.23%78.29M10.12%41.06M-11.27%54.21M0.78%63.95M-24.84%67.36M-49.84%37.29M
Other payable (including interest and dividends) 65.48%181.44M-2.24%64.36M16.82%268.34M1.52%147.44M-9.97%109.64M-7.67%65.83M-3.59%229.7M6.28%145.24M-71.43%121.79M-82.30%71.3M
-Other payable ------------1.52%147.44M-----7.67%65.83M----6.28%145.24M-----82.30%71.3M
Non current liabilities due within one year -11.33%407.56K-66.72%531.82K-26.42%1.31M-12.28%1.68M-39.70%459.63K-37.77%1.6M--1.77M--1.92M--762.18K178.15%2.57M
Other current liabilities 26.89%39.83M7.44%66.59M-22.01%56.63M-23.38%49.26M-63.38%31.39M-39.04%61.98M11.21%72.6M16.56%64.29M61.48%85.73M6.01%101.67M
Total current liabilities -2.01%594.5M-5.66%654.43M3.71%716.96M6.78%634.71M-13.43%606.68M3.94%693.66M8.83%691.35M11.50%594.39M-17.34%700.79M-31.94%667.37M
Current liabilities
Long term account payable --------------0------0------0------0
Specific account payable -------------48.23%61.37M-----41.66%88.51M-----35.65%118.54M-----30.25%151.71M
Deferred tax liabilities 51.62%8.58M54.56%7.94M276.06%6.88M229.59%6.28M185.23%5.66M149.43%5.14M-14.42%1.83M-13.92%1.91M-13.45%1.98M-13.01%2.06M
Long term deferred income -18.90%18.54M-25.63%17.31M3.94%22.02M-0.46%22.44M-4.87%22.86M-8.77%23.27M-42.91%21.19M-43.37%22.54M-43.90%24.03M-43.56%25.51M
Lease liabilities -63.40%1.52M-54.73%1.48M-49.08%1.65M-43.10%1.8M-8.29%4.15M-26.27%3.27M-33.98%3.25M-15.73%3.17M23.29%4.52M319.75%4.43M
Total non current liabilities -47.97%55.48M-47.31%63.33M-38.90%79.79M-37.12%91.9M-35.24%106.64M-34.58%120.19M-38.16%130.58M-36.56%146.16M-34.20%164.66M-31.07%183.71M
Total liabilities -8.88%649.98M-11.81%717.76M-3.06%796.75M-1.88%726.61M-17.58%713.32M-4.37%813.85M-2.89%821.93M-3.00%740.55M-21.18%865.44M-31.76%851.08M
Shareholders equity
Paid-in capital 0.00%919.46M0.00%919.46M0.00%919.46M0.00%919.46M0.00%919.46M0.00%919.46M0.00%919.46M0.00%919.46M0.00%919.46M0.00%919.46M
Capital reserve funds -0.22%1.99B-0.22%1.99B-0.23%1.99B0.26%2B0.30%1.99B0.38%1.99B0.43%1.99B0.46%1.99B0.37%1.99B0.26%1.99B
Surplus reserve funds 5.95%515.32M7.16%515.32M3.13%489.68M3.15%487.16M3.73%486.36M4.54%480.87M3.07%474.81M3.81%472.27M27.82%468.89M29.31%460M
Retained profit 25.70%4.75B24.86%4.38B24.15%4.19B23.19%3.89B25.53%3.78B28.77%3.51B14.09%3.37B15.70%3.16B10.68%3.01B9.00%2.72B
Other composite income -41.95%-1.93M-27.74%-1.34M-96.30%-1.26M6.54%-1.1M-29.45%-1.36M-26.53%-1.05M21.52%-639.45K-73.78%-1.17M-69.88%-1.05M-106.25%-829.94K
Shareholders equity without minority interests 13.87%8.18B13.07%7.8B12.20%7.58B11.50%7.29B12.40%7.18B13.33%6.9B6.95%6.76B7.47%6.54B6.67%6.39B5.80%6.09B
Minority interests 98.93%5.84M55.52%7.89M-60.15%12.39M-101.72%-560.35K-91.63%2.94M-66.71%5.07M--31.09M--32.64M--35.09M--15.24M
Total shareholder equity 13.91%8.18B13.10%7.81B11.86%7.6B10.94%7.29B11.83%7.18B13.13%6.91B7.45%6.79B8.01%6.57B7.26%6.42B6.07%6.1B
Total liabilityies and equity 11.85%8.83B10.48%8.53B10.25%8.39B9.64%8.02B8.34%7.9B10.99%7.72B6.22%7.61B6.78%7.31B2.85%7.29B-0.67%6.96B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg